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Abstract
Background: Patients who have severe narrowing at or near the origin of the internal carotid
artery as a result of atherosclerosis have a high risk of ischaemic stroke ipsilateral to the arterial
lesion. Previous trials have shown that carotid endarterectomy improves long-term outcomes,
particularly when performed soon after a prior transient ischaemic attack or mild ischaemic stroke.
However, complications may occur during or soon after surgery, the most serious of which is
stroke, which can be fatal. It has been suggested that performing the operation under local
anaesthesia, rather than general anaesthesia, may be safer. Therefore, a prospective, randomised
trial of local versus general anaesthesia for carotid endarterectomy was proposed to determine
whether type of anaesthesia influences peri-operative morbidity and mortality, quality of life and
longer term outcome in terms of stroke-free survival.
Methods/design: A two-arm, parallel group, multicentre randomised controlled trial with a
recruitment target of 5000 patients. For entry into the study, in the opinion of the responsible
clinician, the patient requiring an endarterectomy must be suitable for either local or general
anaesthesia, and have no clear indication for either type. All patients with symptomatic or
asymptomatic internal carotid stenosis for whom open surgery is advised are eligible. There is no
upper age limit. Exclusion criteria are: no informed consent; definite preference for local or general
anaesthetic by the clinician or patient; patient unlikely to be able to co-operate with awake testing
during local anaesthesia; patient requiring simultaneous bilateral carotid endarterectomy; carotid
endarterectomy combined with another operation such as coronary bypass surgery; and, the
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patient has been randomised into the trial previously. Patients are randomised to local or general
anaesthesia by the central trial office. The primary outcome is the proportion of patients alive,
stroke free (including retinal infarction) and without myocardial infarction 30 days post-surgery.
Secondary outcomes include the proportion of patients alive and stroke free at one year; health
related quality of life at 30 days; surgical adverse events, re-operation and re-admission rates; the
relative cost of the two methods of anaesthesia; length of stay and intensive and high dependency
bed occupancy.
Trial registration: Current Controlled Trials ISRCTN00525237
Background
Patients who have severe narrowing at or near the origin
of the internal carotid artery as a result of atherosclerosis
have a high risk of ischaemic stroke ipsilateral to the arte-
rial lesion. Carotid endarterectomy to remove the lesion is
often advised, particularly soon after a prior transient
ischaemic attack or mild ischaemic stroke. It is less often
appropriate if the arterial lesion is asymptomatic. The
operation involves surgical exposure of the carotid artery
followed by removal of the atheromatous plaque that is
causing narrowing of the artery.
A number of complications may occur during or soon
after carotid endarterectomy, the most serious of which is
a stroke (5–7% of cases), which can be fatal. Nonetheless,
two large multicentre trials have confirmed the advantage
of surgery in the long-term prevention of ischaemic stroke
ipsilateral to the operation, for symptomatic patients [1]
and there may also be some advantages for asymptomatic
stenosis patients [2]. However, the complications of sur-
gery cannot be dismissed and anything that might reduce
their frequency would be very important. One option is to
do the operation not under general anaesthesia which is
the most usual practice, but under local or regional anaes-
thesia because it may be safer. Both techniques have been
in widespread use ever since the operation was introduced
in the late 1950s.
In a meta-analysis [3] of 41 non-randomised studies
(25,622 patients) and seven randomised studies (554
patients), carotid endarterectomy under local anaesthesia
was associated with about a 40% reduction in the relative
odds of peri-operative stroke or death. Whilst this is of
considerable interest, the findings must be viewed with
caution. Almost all the data came from the non-ran-
domised studies, which are susceptible to publication
bias, patient selection bias and the unequal distribution
of risk factors at baseline. Many studies were retrospective
and included non-consecutive patients. Furthermore, the
distribution of patients with asymptomatic stenosis (low
risk), and variations in surgical technique and antiplatelet
therapy were biased in favour of local anaesthesia. As a
result, this review can only assist in the generation of a
hypothesis for further examination.
The potential benefits of local anaesthesia in a wider range
of surgical procedures is supported by an overview of ran-
domised trials of spinal and epidural anaesthesia versus
general anaesthesia; mortality was reduced by about one-
third in patients allocated to neuraxial block [4]. Compli-
cations of surgery were also reduced, but again sample
sizes were small and many different types of patient and
procedure were combined in the analysis. In addition, a
number of studies were confounded by the use of regional
anaesthesia as an adjunct to general anaesthesia.
Therefore, a prospective, randomised trial of local versus
general anaesthesia for carotid endarterectomy is pro-
posed to determine whether the type of anaesthesia does
indeed influence peri-operative morbidity and mortality,
quality of life and long term outcome in terms of stroke-
free survival. If so, this finding might be generalisable to
other surgical procedures, or at least encourage further
randomised controlled trials.
Design and methods
GALA is a two-arm, parallel group, multicentre ran-
domised controlled trial. Patients will be randomised to
either surgery under local anaesthesia (superficial and
deep cervical plexus nerve block) or general anaesthesia.
Ethical approval was obtained from the Northern and
Yorkshire Multicentre Research Ethics Committee for the
pilot phase in August 1998 and for the main phase in
April 2003.
Primary outcome
The primary outcome is the proportion of patients alive
and stroke-free (including retinal infarction) and without
myocardial infarction at 30 days after surgery, or 30 days
after randomisation for those few patients for whom sur-
gery was scheduled but was never carried out.
Setting
Each trial centre must be experienced in carotid surgery (at
least 15 procedures per consultant surgeon per annum)
and have local research ethics approval. Each centre will
provide the Trials Office with the number of patients
operated on in the previous year, and of them, how many
had local anaesthesia. Preoperative assessment of carotidTrials 2008, 9:28 http://www.trialsjournal.com/content/9/1/28
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disease and the technical aspects of surgery will be what-
ever is the standard practice in trial centres.
The issue of surgical procedures performed by trainees is
difficult. Ideally either all surgery performed within the
study should be undertaken by a trained consultant vascu-
lar surgeon, or equal numbers of patients in each arm of
the study should be operated on by trainees under super-
vision. Although the latter is likely to better match current
clinical practice, there may be some difficulty in ensuring
that this actually happens. Individual centres will there-
fore be asked to monitor this carefully if it is their inten-
tion to allow trainees to operate on study patients. A
further check will be made in the Trials Office, and any
necessary feedback provided to the participating centres to
ensure as far as possible that similar proportions of
patients in each treatment arm are operated on by consult-
ants and trainees. The alternative, that only non-ran-
domised patients provide the focus for training, is not
ethically acceptable. The same issue applies to trainee
anaesthetists.
Inclusion criteria
Any patient requiring carotid endarterectomy, who is con-
sidered suitable for either local or general anaesthesia. All
patients with either symptomatic or asymptomatic inter-
nal carotid stenosis for whom surgery is advised are eligi-
ble. There is no upper age limit. Fully informed consent is
required from all patients.
Exclusion criteria
• Unable to obtain informed consent.
• Patient unlikely to be able to co-operate with awake test-
ing during local anaesthesia.
• Patient considered unfit for general anaesthesia.
• Patient considered unfit for local anaesthesia.
• Patient requiring simultaneous bilateral carotid endar-
terectomy.
• Carotid endarterectomy combined with another opera-
tive procedure, e.g. coronary artery bypass surgery
• Patient has been randomised into the trial previously
Intervention
Some may believe that many characteristics of the study
groups should be strictly standardised, including: the
exact indications for surgery, diagnostic methods, anaes-
thetic techniques, surgical techniques (indications for,
and the use of shunts; heparin dose; patching etc), intra-
operative monitoring, post-operative assessment,
antiplatelet therapy, and the proportion of procedures
undertaken by surgical trainees. This is impractical in the
context of a multicentre international study and unneces-
sary. With the exception of the following, we suggest that
current practices and protocols within trial centres should
continue unchanged (of course, data on all of the above
will be collected): 1. The issue of trainees discussed above;
2. Shunts should generally only be used in the local anaes-
thesia patients when awake neurological testing indicates
a need, this being an inevitable and central part of the pro-
tocol for the local anaesthesia approach.
As a result of this pragmatic approach the results will be
more generalisable since we will be comparing the out-
come of surgery under either local or general anaesthesia
in real clinical settings where procedures are not necessar-
ily all performed in exactly the same way between centres,
or even between surgeons in the same centre.
As far as the anaesthetic techniques employed in this
study are concerned a pragmatic approach to standardisa-
tion will also be taken. In other words each centre will
continue with their standard anaesthetic protocol. Strict
guidelines on anaesthetic management are unnecessary
given that each surgical procedure is a 'package' of anaes-
thetic and surgical care. In general terms the anaesthetic
protocols shown in table 1 should be used.
In summary, the study will allow participating centres to
continue to undertake carotid endarterectomy in the same
way as they currently practice, with no specific constraints
or restrictions.
The technique of superficial and deep cervical nerve block
is familiar to many anaesthetists, particularly those who
work in pain clinics. For those centres that are not familiar
with this technique two alternatives are available. Firstly,
any anaesthetist/surgeon can visit the General Infirmary at
Leeds to observe one or more procedures. Secondly, a
video of both the administration of local anaesthesia and
the 'in-theatre' set-up for surgery is available. Before ran-
domising any patients, each centre is expected to have
done at least five procedures under local anaesthesia.
Sample size
The study requires 5,000 patients to demonstrate a clini-
cally worthwhile difference between the two anaesthesia
techniques in the primary outcome – based on a predicted
one third reduction in the risk of stroke (including retinal
infarction), myocardial infarction or death within 30 days
of surgery, when it is performed under local as compared
with general anaesthesia (from 7.5% to 5%, a more con-
servative treatment effect than suggested by the meta-anal-
ysis). This sample will provide a more than 90% chance of
detecting this treatment difference at the 5% level.Trials 2008, 9:28 http://www.trialsjournal.com/content/9/1/28
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To recruit 5,000 patients by the end of 2007 we will need
at least 100 centres in the UK, mainland Europe, and else-
where if particularly interested.
Randomisation
Randomisation is stratified by centre and uses balanced
blocks of variable size. The randomised treatment alloca-
tion is provided centrally by the Trials Office in Edin-
burgh. Balance between the two groups is checked
periodically by the trial statistician. Baseline data are col-
lected by the local collaborator, written on a randomisa-
tion note pad [see Additional file 1], and faxed to the
Trials Office who then fax back the randomised treatment
allocation.
Because all outcomes will be counted and analysed from
the moment of randomisation, it is important that ran-
domisation itself occurs fairly close to the day of surgery –
perhaps the day before, or a few days before at most. To
allow patients to think about consent to randomisation,
more time for reflection may well be required, so the con-
sent process might be usefully carried out during the clinic
appointment when surgery itself is discussed. So the gen-
eral rule is 'consent early, but randomise late'. Exactly how
this process gets done will depend on local factors in each
centre.
From the moment of randomisation the patient is consid-
ered to be in the trial and accounted for in the analysis
whether or not they received the allocated treatment inter-
vention, or even surgery at all, i.e. the analysis is on an
intention-to-treat basis unless otherwise stated.
Data collection at baseline
Factors which might predict surgical risk and long-term
vascular events are recorded and the data checked in the
Trials Office for completeness and consistency. Data to be
collected include: demographic information, details of
the cerebrovascular event(s), vascular risk factors, diag-
nostic procedures and findings (brain and arterial imag-
ing), indications for surgery and illness severity grading.
Data collection at 7 days post-operatively, hospital 
discharge or death
Data collection forms [see Additional file 2] are supplied
to each centre and the completed forms posted or faxed
back to the Trials Office. Data to be collected comprise
details of the surgery and anaesthetic, and outcomes. The
surgical data collected include the date the surgical proce-
dure was carried out, reasons for not having surgery at all
or for surgery to be abandoned before completion, details
of the anaesthesia used, reasons for any cross over from
allocated treatment, skin incision to skin closure duration
of surgery. We also collect the grade of the surgeon and
anaesthetist (consultant or trainee), recovery room/inten-
sive care/high dependency unit occupancy, and length of
stay. The outcome data collected include stroke (including
retinal infarction), with severity determined by modified
Rankin scale six months after onset by post to the patient's
general practitioner (or other appropriate physician);
myocardial infarction; death (and cause); transient
ischaemic attacks; other complications e.g. re-operation,
neck haematoma, respiratory or urinary problems, cranial
nerve palsy etc.
Data collection at one month
Data collection forms [see Additional file 3] are supplied
to each centre and the completed forms are posted or
faxed to the Trials Office. The following data are collected
by an independent stroke physician or neurologist as
'blind' as possible to the type of anaesthesia that the
patient received; stroke (including retinal infarction),
severity determined by modified Rankin scale six months
after onset by post to the patient's general practitioner (or
other appropriate physician); myocardial infarction;
death (and cause); transient ischaemic attacks; and other
complications, respiratory problems, or cranial nerve
palsy.
Table 1: Anaesthesia protocols
General anaesthesia Local anaesthesia
Premedication: benzodiazepine or none Premedication: benzodiazepine or none
Intravenous access + arterial line under local anaesthetic Intravenous access + arterial line under local anaesthetic
Intravenous induction + opiate analgesia Judicious conscious sedation (e.g. benzodiazepine/opiate)
Muscle relaxant Deep and superficial cervical plexus block + local infiltration (e.g. with 
bupivacaine)
Tracheal intubation, ventilation to normocapnia Intra-operative top-up of local anaesthetic if required (lignocaine)
Maintain systemic blood pressure to pre-operative levels with 
intravenous fluids/cardioactive drugs if required
Maintain systemic blood pressures to pre-operative levels with 
intravenous fluids/cardioactive drugs if required
Reversal of anaesthetic and extubation O2 as necessary by nasal cannulae/mask, in particular during cross-
clamping of carotid vessels
Oxygen overnight by nasal cannulae/mask
Each trial centre will continue with their standard anaesthesia protocol. Strict guidelines on anaesthetic management are unnecessary given that 
each surgical procedure is a 'package' of anaesthetic and surgical care. In general terms the anaesthesia protocols in this table should be used.Trials 2008, 9:28 http://www.trialsjournal.com/content/9/1/28
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Separate forms are also sent by post direct to all UK
patients from the Trials Office to collect quality of life data
(SF36 and EuroQol). Non-UK patients do not receive this
questionnaire.
Follow-up at one year
Follow-up at one year will be preceded by contacting each
patient's General Practitioner or other relevant physician
to ensure that the patient is still alive and suitable for a fol-
low-up questionnaire on paper. The following data will be
collected: stroke (including retinal infarction), severity
determined by modified Rankin scale six months after
onset by post to the patient's general practitioner (or other
appropriate physician); death (and cause); myocardial
infarction; whether the patient is currently smoking; any
medications for high blood pressure, lipid lowering and
antithrombotic (to ensure there is no systematic bias in
the use of co-interventions which could affect stroke risk).
In non-UK countries different arrangements will be made
for annual follow-up, probably telephone contact by a
stroke physician from one of the country trial centres.
Checking and auditing primary outcomes
Details of any stroke (including retinal infarction), myo-
cardial infarction and death are collected by the Trials
Office and a clinician (as blind as possible to treatment
allocation) prepares a clinical summary. This summary is
then sent to an independent neurologist or cardiologist
for audit, completely blinded to treatment allocation.
Information is requested from hospital notes, death certif-
icates and general practitioner records where appropriate.
Enquiry is also made to ensure that any reported transient
ischaemic attacks are not in fact minor strokes. Stroke is
defined by the usual World Health Organisation criteria
using a 24-hour cut off from transient ischaemic attacks.
Myocardial infarction and other coronary events are
defined on the basis of the history, electrocardiogram and
cardiac enzymes.
Data analysis
Data analysis will be performed by the Principal Investiga-
tors in collaboration with the trial statistician at the Neu-
rosciences Trials Unit, Edinburgh University. Trial data
will be presented according to the CONSORT guidelines
[5]. All analyses unless otherwise stated will be by inten-
tion-to-treat and will compare all patients allocated to
general anaesthesia with all those allocated to local anaes-
thesia. For the primary outcome, we will present the rela-
tive and absolute differences in the proportion of patients
alive and stroke-free (including retinal infarction) and
without myocardial infarction at 30 days after surgery, or
30 days after randomisation for those few patients for
whom surgery was scheduled but was never carried out. A
variety of other secondary analyses (with due allowance
for their exploratory nature) will be performed to com-
pare: survival to 30 days post-surgery, other peri-operative
adverse events; survival analysis of stroke, myocardial inf-
arction and death in the longer term at one year; length of
stay in recovery, high dependency unit, intensive therapy
unit and overall; and health related quality-of-life at about
30 days post-surgery.
Health economic analysis
Our systematic review suggested that patients having sur-
gery under local anaesthesia spend less time in intensive
care and in hospital. This is not a robust finding since only
six studies gave relevant data and only two indicated the
duration of intensive care. In GALA we will collect data on
length of stay in various parts of the hospital, and the
number and estimated costs of strokes during follow-up,
because if local anaesthesia reduces the number of strokes
this will be an important cost saving. As well as estimating
the differential costs of the two approaches, we will, if
local anaesthesia is shown to be clinically superior, under-
take a modelling study to estimate the likely cost utility of
carotid endarterectomy once the clinical risk benefit ratio
has been altered. If local anaesthesia were shown to be
superior it is likely to encourage surgeons to operate on
lower risk (without surgery) patients and higher risk (with
surgery) patients than at present. We wish to see if such a
clinical policy is cost effective.
A priori subgroups
We will present the relative and absolute differences in the
proportion of patients alive and stroke-free without myo-
cardial infarction at 30 days post surgery subdivided by:
low baseline risk of surgical stroke or death versus high
baseline risk of surgical stroke or death using a previously
published model [6]; by age (i.e. young versus old); and
by contralateral versus no contralateral carotid occlusion.
Sensitivity analysis
Although unlikely, it is conceivable that surgeons begin-
ning to operate under an unfamiliar anaesthetic regime
(more likely local than general) may have more operative
problems than usual. We will be discussing how to ana-
lyse the trial without the 'learning curve' with colleagues
and the Data Monitoring Committee.
Generalisability of the trial results
The results of this trial can be applied to similar patients
in the future. It is, therefore, very important to describe in
detail the characteristics of the patients randomised, as we
will do. Inevitably, there will be some eligible patients
who, for some reason, do not get randomised. However,
our inclusion criteria are broad, and we envisage that
across all centres, a very wide variety of patients will be
randomised. We will collect the numbers of operated
patients in each trial centre to gain some idea of the over-Trials 2008, 9:28 http://www.trialsjournal.com/content/9/1/28
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all experience of the centre and what proportion of their
patients enter the trial.
Organisation
The Steering Committee will usually meet every six
months to review the progress of the trial, including the
overall complication rates of surgery. However, apart from
the trial statistician, all the members of the committee will
remain blinded to any outcomes and other important
results divided by treatment allocation.
All members of the Data Monitoring Committee will be
totally independent of the trial. The Data Monitoring
Committee will regularly review the recruitment into the
trial, trial discipline, the baseline data and the main out-
comes. They will advise the Steering Committee on the
adequacy of recruitment, the balance of the two treatment
arms, and that there is no accumulating evidence of harm
to one arm or the other. In this task they may request
whatever unblinded analyses they wish from the trial stat-
istician, and at whatever interval they wish. The Commit-
tee may also wish to consider any new information arising
from other studies. All unblinded analyses are supplied to
the Data Monitoring Committee in confidence.
The Data Monitoring Committee will advise the chairman
of the Steering Committee if, in their view, the ran-
domised comparisons have provided both: (i) 'proof
beyond reasonable doubt' that for all, or some patients,
one method of anaesthesia is clearly indicated or clearly
contra-indicated; and (ii) evidence that might reasonably
be expected to materially influence future patient manage-
ment. Appropriate criteria of proof beyond reasonable
doubt cannot be specified precisely, but we imagine the
DMC will work to the well established guide that a differ-
ence of at least 3 standard errors in an interim analysis of
the primary outcome events (between patients allocated
local anaesthesia and patients allocated general anaesthe-
sia) may be needed to justify halting or modifying the
study before the planned completion of recruitment. This
criterion has the practical advantage that the exact number
of interim analyses is of little importance, and so no fixed
schedule is proposed.
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